Clinical data | |
---|---|
Trade names | Ixel, Joncia, Savella, Dalcipran, others |
Other names | Milnacipran hydrochloride |
AHFS/Drugs.com | Monograph |
MedlinePlus | a609016 |
Pregnancy category |
|
Routes of administration | By mouth (tablets), capsules) |
Drug class | Serotonin–norepinephrine reuptake inhibitor (SNRI)[1] |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 85% |
Protein binding | 13% |
Metabolism | Liver |
Elimination half-life | 8 hours |
Excretion | Kidney |
Identifiers | |
| |
Chemical and physical data | |
Formula | C15H22N2O |
Molar mass | 246.354 g·mol−1 |
3D model (JSmol) | |
Chirality | Racemic mixture |
| |
| |
(verify) |
Milnacipran, sold under the brand name Savella among others, is a medication used to treat fibromyalgia and major depressive disorder.[1] It is taken by mouth.[1]
Common side effects include nausea, headache, trouble sleeping, increased sweating, and palpitations.[1] Other side effects may include suicide in those under 25 years old, serotonin syndrome, increased blood pressure, liver problems, bleeding, and mania.[1] Safety in pregnancy is unclear.[1] It is a serotonin–norepinephrine reuptake inhibitor (SNRI).[1]
Milnacipran was approved for medical use in the United States in 2009.[1] It was denied approval in Europe in 2009 due to questionable benefits.[2] In the United States it costs about 420 USD for a month as of 2021.[3]
References edit
- ^ a b c d e f g h i j k "Milnacipran Monograph for Professionals". Drugs.com. Archived from the original on 27 February 2021. Retrieved 18 November 2021.
- ^ "Milnacipran Pierre Fabre Medicament". Archived from the original on 22 September 2020. Retrieved 18 November 2021.
- ^ "Savella Prices, Coupons & Savings Tips - GoodRx". GoodRx. Archived from the original on 17 August 2021. Retrieved 18 November 2021.